Streetbeat News

Revenues

GH

Guardant Health has announced FDA approval and Medicare coverage for its Shield blood test, which is now commercially available as the first FDA-approved blood test for primary colorectal cancer screening.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:33 pm

ITRI

Itron (NASDAQ:ITRI) reported strong Q2 earnings, with adjusted EPS of $1.21 beating the $0.96 estimate and sales of $609.07M surpassing the $599.10M estimate. This represents significant year-over-year growth in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:31 pm

PNW

Pinnacle West Capital (NYSE:PNW) reported Q2 2024 GAAP EPS of $1.76, beating the estimate of $1.34 by 31.34%. Sales were $1.309 billion, surpassing the $1.208 billion estimate and showing a 16.67% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:31 pm

SPY

The USA's continuing jobless claims have risen to 1,877K, surpassing the estimated 1,860K and the prior revised figure of 1,844K.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:30 pm

SPY

Nonfarm productivity for Q2 increased by 2.3%, surpassing the estimated 1.7%.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:30 pm

NREF

NexPoint Real Estate Finance (NREF) reported Q3 EPS between $0.39 and $0.49, compared to an estimate of $0.48. The company provided guidance for Q3 2024, with EAD per diluted share expected to be $0.505 at the midpoint. Net income attributable to common stockholders is projected to range from $9.128 million to $11.470 million.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:29 pm

LAB

Standard BioTools shares are trading lower after the company reported worse-than-expected Q2 financial results and cut FY24 revenue guidance below estimates. Additionally, CFO Jeffery Black will resign.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:28 pm

NREF

NexPoint Real Estate (NYSE:NREF) reported Q2 2024 adjusted EPS of $0.68, beating the $0.45 estimate by 51.11%. However, sales of $6.740M missed the $18.167M estimate by 62.90%, though it represents a 60.29% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:23 pm

BYDDF

FXI

TSLA

BYD reported July vehicle sales of 342,383 units, with passenger vehicle sales at 340,799 units. Plug-in hybrid passenger EV sales were 210,799 units, and battery passenger EV sales were 130,000 units.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:19 pm

IDA

Idacorp (NYSE:IDA) reported strong Q2 2024 earnings, with GAAP EPS of $1.71 beating the $1.39 estimate and sales of $451.039M surpassing the $440.150M estimate. This represents a 26.67% increase in EPS and an 8.99% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:14 pm